Symbols

GEHC

GE HealthCare·NASDAQ

--(--)

GEHC fundamentals

GEHC Q4 2025 Earnings

GE HealthCare (GEHC) released its earnings on Feb 4, 2026: revenue was 5.70B (YoY +7.13%), beat estimates; EPS was 1.44 (YoY -0.69%), beat estimates.

Revenue / YoY

5.70B

+7.13%

EPS / YoY

1.44

-0.69%

Report date

Feb 4, 2026

GEHC Earnings Call Summary for Q4,2025

Q4 Strong Performance: 4.8% organic growth, $5.7B revenue, and $1.44 EPS despite $100M tariffs.
Flyrcardo Momentum: 220 weekly doses, 95% CMO on-time rate, targeting $500M+ by 2028.
Heartbeat Efficiency: 25% backlog reduction, improving margins and cash flow.
2026 Outlook: 3-4% growth, 15.8-16.1% EBIT margin, and $4.95-$5.15 EPS driven by new products and cost control.

Earnings

EPS

Revenue

Revenue & Expenses

GEHC has released its 2025 Q4 earnings report, with revenue of 5.70B, reflecting a YoY change of 7.13%, and net profit of 602.00M, showing a YoY change of -18.43%. The Sankey diagram below clearly presents GEHC's revenue sources and cost distribution.

Key Indicators

GE HealthCare (GEHC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

GE HealthCare (GEHC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

GE HealthCare (GEHC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

GE HealthCare (GEHC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown